CNS5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS) ==== | ====CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)==== | ||
| | | | ||
---- | ---- | ||
| Line 338: | Line 338: | ||
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]] | |[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]] | ||
|Disease | |Disease | ||
|Laveniya Satgunaseelan | |||
|9/11/2024 | |||
| | | | ||
|Pending | |||
| | | | ||
| | | | ||
| | | | ||
| | |Testing 9/2024 somatic template | ||
|- | |- | ||
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]] | |[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]] | ||
| Line 535: | Line 535: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 3 (CHOROID PLEXUS TUMOURS) ==== | ====CHAPTER 3 (CHOROID PLEXUS TUMOURS)==== | ||
| | | | ||
---- | ---- | ||
| Line 589: | Line 589: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 4 (EMBRYONAL TUMOURS) ==== | ====CHAPTER 4 (EMBRYONAL TUMOURS)==== | ||
| | | | ||
---- | ---- | ||
| Line 742: | Line 742: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 5 (PINEAL TUMOURS) ==== | ====CHAPTER 5 (PINEAL TUMOURS)==== | ||
| | | | ||
---- | ---- | ||
| Line 829: | Line 829: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS) ==== | ====CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)==== | ||
| | | | ||
---- | ---- | ||
| Line 938: | Line 938: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 7 (MENINGIOMA) ==== | ====CHAPTER 7 (MENINGIOMA)==== | ||
| | | | ||
---- | ---- | ||
| Line 970: | Line 970: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS) ==== | ====CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)==== | ||
| | | | ||
---- | ---- | ||
| Line 1,123: | Line 1,123: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 9 (MELANOCYTIC TUMOURS) ==== | ====CHAPTER 9 (MELANOCYTIC TUMOURS)==== | ||
| | | | ||
---- | ---- | ||
| Line 1,166: | Line 1,166: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS) ==== | ====CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)==== | ||
| | | | ||
---- | ---- | ||
| Line 1,352: | Line 1,352: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 11 (GERM CELL TUMOURS) ==== | ====CHAPTER 11 (GERM CELL TUMOURS)==== | ||
| | | | ||
---- | ---- | ||
| Line 1,384: | Line 1,384: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 12 (TUMOURS OF THE SELLAR REGION ==== | ====CHAPTER 12 (TUMOURS OF THE SELLAR REGION==== | ||
| | | | ||
---- | ---- | ||
| Line 1,471: | Line 1,471: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 13 (METASTASES TO THE CNS) ==== | ====CHAPTER 13 (METASTASES TO THE CNS)==== | ||
| | | | ||
---- | ---- | ||
| Line 1,514: | Line 1,514: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS) ==== | ====CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)==== | ||
| | | | ||
---- | ---- | ||